Project CASK Canada has joined the PC Global Network as its first international affiliate, sharing one Scientific Advisory Board and one Global CASK Therapeutic Roadmap. A milestone that marks the beginning of coordinated global research funding for CASK gene disorders, compounding the impact of parent-led investment across borders.

Project CASK has been named a collaborator in the Critical Path Institute TRxA 2026 BRIDGe program, an FDA-partnered drug development initiative. A CASK gene disorder submission has been accepted into the program, marking a meaningful step toward clinical translation for CASK-related disorders.